This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, M. M.
Right arrow Articles by Macaulay, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, M. M.
Right arrow Articles by Macaulay, S. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 1999, p. 7771-7781, Vol. 19, No. 11
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

A Role for Protein Kinase Bbeta /Akt2 in Insulin-Stimulated GLUT4 Translocation in Adipocytes

Michelle M. Hill,1 Sharon F. Clark,1 David F. Tucker,2 Morris J. Birnbaum,3 David E. James,1,* and S. Lance Macaulay2

Centre for Molecular and Cellular Biology and Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072,1 and CSIRO Health Sciences and Nutrition, Parkville, Victoria 3052,2 Australia, and Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-61483

Received 21 June 1999/Returned for modification 23 July 1999/Accepted 19 August 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Insulin stimulates glucose uptake into muscle and fat cells by promoting the translocation of glucose transporter 4 (GLUT4) to the cell surface. Phosphatidylinositide 3-kinase (PI3K) has been implicated in this process. However, the involvement of protein kinase B (PKB)/Akt, a downstream target of PI3K in regulation of GLUT4 translocation, has been controversial. Here we report that microinjection of a PKB substrate peptide or an antibody to PKB inhibited insulin-stimulated GLUT4 translocation to the plasma membrane by 66 or 56%, respectively. We further examined the activation of PKB isoforms following treatment of cells with insulin or platelet-derived growth factor (PDGF) and found that PKBbeta is preferentially expressed in both rat and 3T3-L1 adipocytes, whereas PKBalpha expression is down-regulated in 3T3-L1 adipocytes. A switch in growth factor response was also observed when 3T3-L1 fibroblasts were differentiated into adipocytes. While PDGF was more efficacious than insulin in stimulating PKB phosphorylation in fibroblasts, PDGF did not stimulate PKBbeta phosphorylation to any significant extent in adipocytes, as assessed by several methods. Moreover, insulin, but not PDGF, stimulated the translocation of PKBbeta to the plasma membrane and high-density microsome fractions of 3T3-L1 adipocytes. These results support a role for PKBbeta in insulin-stimulated glucose transport in adipocytes.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The ability of insulin to promote glucose storage in muscle and adipose tissue is crucial to the maintenance of glucose homeostasis. An impairment in the ability of insulin to stimulate glucose uptake in these tissues, a condition termed insulin resistance, contributes to the development of type 2 (non-insulin-dependent) diabetes, hypertension, and cardiovascular disease (25). The primary mechanism of insulin-stimulated glucose uptake is through the translocation of glucose transporter 4 (GLUT4) from an intracellular site to the cell surface (26). Defects in the insulin signal transduction pathways that regulate glucose transport have been considered likely causes of insulin resistance (28).

While the insulin signaling pathways responsible for triggering GLUT4 translocation are yet to be defined, rapid progress has been made. Activation of the insulin receptor results in the tyrosyl phosphorylation of insulin receptor substrate (IRS) proteins, docking proteins that recruit src homology 2-containing signaling proteins via phosphotyrosine moieties. Several lines of evidence suggest the involvement of IRS proteins in insulin-stimulated GLUT4 translocation. Disruption of IRS-1 and IRS-2 in mice causes mild insulin resistance and type 2 diabetes, respectively (6, 60). Overexpression of IRS-1 in rat adipocytes mimics the effect of insulin on GLUT4 translocation (43), while reduction of IRS-1 by an antisense ribozyme (43) or chronic insulin treatment (44) decreases insulin responsiveness. One of the molecules recruited by IRS proteins thought to be required for insulin-stimulated GLUT4 translocation is phosphatidylinositide 3-kinase (PI3K). Two inhibitors of PI3K, wortmannin and LY294002, both inhibit insulin-stimulated GLUT4 translocation (14, 17, 42). Furthermore, introduction of a dominant negative p85 regulatory subunit into adipocytes significantly impairs insulin-stimulated GLUT4 translocation either when microinjected (31) or when overexpressed (47). Overexpression of constitutively active p110 catalytic subunit stimulates GLUT4 translocation to the plasma membrane (PM) in the absence of insulin (38, 53). Hence, these experiments collectively suggest that PI3K is necessary for insulin-stimulated GLUT4 translocation.

Several protein serine/threonine kinases have recently been identified as downstream targets of PI3K. These include protein kinase B (PKB; cellular homolog of v-AKT, also termed RAC-PK) (11, 20, 22), PKCzeta (8, 50), and PKClambda (32). Several studies have examined the role of PKB in insulin-stimulated GLUT4 translocation; however, the results have been somewhat contradictory. Constitutively active PKBalpha has been expressed in either 3T3-L1 adipocytes (30) or rat adipocytes (18, 54) and found to promote GLUT4 translocation to the plasma membrane. Similarly, constitutively active PKBalpha increased glucose uptake in L6 myotubes (23, 57). Studies utilizing dominant negative PKB have produced conflicting results. In support of a role for PKB in insulin action, Cong et al. (18) found that a kinase-inactive (K179A) PKBalpha mutant inhibited insulin-stimulated GLUT4 translocation by 20% when transfected into rat adipocytes. However, Hajduch et al. (23) found that this same construct had no significant effect in L6 myotubes. Similarly, two recent studies (29, 32) found that a double-phosphorylation site mutant of PKBalpha behaved as a dominant negative mutant with respect to 3T3-L1 adipocyte PKB activity measured in vitro but had no significant effect on insulin-stimulated GLUT4 translocation. In contrast, a kinase-inactive, phosphorylation-deficient mutant of PKBalpha was found to inhibit insulin-stimulated GLUT4 translocation in L6 myoblasts (59). Part of the difficulty in reconciling these results lies in the complexity of PKB regulation, which is only beginning to be deciphered. The use of different cell types, some of which may not be bona fide insulin-responsive cells, has also complicated the interpretation. In addition, chronic overexpression of mutant forms of PKB may enable the cell to adapt via alternate pathways. Another potential problem is isoform specificity. Three isoforms of PKB have been identified; however, these were not distinguished in most studies examining the role of PKB in insulin-stimulated glucose uptake. While all of the PKB mutants studied were based on PKBalpha , PKBbeta was recently identified as the isoform that associates with GLUT4 vesicles in an insulin-dependent manner in rat adipocytes (12). Interestingly, PKBbeta appears to be functionally distinct from PKBalpha and PKBgamma , as stress activates PKBalpha and PKBgamma , but not PKBbeta (48).

To further assess the role of PKB in insulin stimulation of GLUT4 translocation, we have utilized a different approach from previous studies. Microinjection of specific substrate peptides and antibodies was used to acutely inhibit endogenous PKB action. Microinjection of a PKB substrate peptide (KRPRAATF) caused significant inhibition of insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. An antibody directed against the N terminus of PKBalpha , which also recognizes PKBbeta , produced similar effects. We further show that PKBbeta expression is switched on during adipocyte differentiation whereas PKBalpha is down-regulated. Concomitant with this change, we also observed a switch in growth factor responsiveness during differentiation in that the ability of platelet-derived growth factor (PDGF) to stimulate PKB phosphorylation is switched off in adipocytes at the expense of a robust activation by insulin. Taken together, our results strongly support PKBbeta as the isoform involved in mediating the metabolic effects of insulin in adipocytes.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Antibodies. Rabbit antibodies directed against the N terminus of PKBalpha (residues 3 to 22) were purchased from Santa Cruz Biotechnology (N19; Santa Cruz, Calif.). Sheep antibodies against PKBalpha (residues 466 to 480), PKBbeta (residues 455 to 469, as described in reference 58), and PKBgamma (residues 116 to 128) were purchased from Upstate Biotechnology Inc. (Lake Placid, N.Y.). Rabbit PKBbeta antibodies were raised against a C-terminal peptide of PKBbeta (CDQTHFPQFSYSASIRE). Antibodies specific for PKB phosphorylated at Ser473 or Thr308 were purchased from New England Biolabs (Beverly, Mass.). Monoclonal antihemagglutinin (anti-HA) antibodies (HA11, clone 16B12) were purchased from BabCo (Berkeley, Calif.). Polyclonal anti-GLUT4 antibodies (R017) were raised in rabbits against a 17-amino-acid peptide comprising the C terminus of GLUT4.

Peptide synthesis. Peptides were synthesized with an Applied Biosystems 430A Peptide synthesizer coupled with the FastMoc strategy. Purity was checked by reverse-phase high-pressure liquid chromatography, and their integrity was confirmed by amino acid analysis and matrix-assisted laser desorption ionization mass spectrometry. Two peptides were examined. KRPRAATF was a peptide closely related to that reported by Alessi et al. (1) as a specific substrate for PKB, except that we included a lysine to increase its solubility in aqueous solutions. KRPRAAAF was the same peptide, except that alanine was substituted for threonine. The first peptide was found to be a good substrate for PKB in in vitro assays. The alanine-substituted peptide partially inhibited PKB phosphorylation of the substrate peptide only at the highest concentration tested (1 mg/ml) (data not shown).

Cell culture. 3T3-L1 fibroblasts (American Type Culture Collection) were grown and differentiated into adipocytes as described elsewhere (55). Briefly, 3T3-L1 fibroblasts were grown and passaged in Dulbecco's modified Eagle medium supplemented with 10% newborn calf serum. Cells were differentiated 1 to 2 days postconfluence. The differentiation medium contained 10% fetal calf serum (FCS), 250 nM dexamethasone, 500 nM isobutyl methylxanthine, and 500 nM insulin. After 3 days, the differentiation medium was replaced with postdifferentiation medium containing 10% FCS and 250 nM insulin. Cells were fed every 3 days postdifferentiation in Dulbecco's modified Eagle medium supplemented with 10% FCS. Unless otherwise stated, fibroblasts were used at confluence and adipocytes were used at 8 to 15 days after the initiation of differentiation. 3T3-L1 fibroblasts stably expressing HA-PKBalpha or HA-PKBbeta have been described elsewhere (52).

Microinjection. Microinjection was performed as previously described (35). Cells grown to confluence and differentiated on coverslips were transferred to Krebs-Ringer bicarbonate buffer (111 mM NaCl, 4.87 mM KCl, 1.15 mM CaCl2, 1.22 mM KH2PO4, 1.21 mM MgSO4, 25.7 mM NaHCO3, 10 mM HEPES, 2.5 mM glucose, 0.5% bovine serum albumin [BSA], 1 mM Na pyruvate, pH 7.4) for 45 min. They were microinjected over a 45-min period with a Zeiss automated injection system (Carl Zeiss, Oberkochen, Germany) coupled to an Eppendorf (Hamburg, Germany) microinjector. Micropipettes were prepared with a Sutter (Novato, Calif.) P-97 micropipette puller. Reagents for microinjection were dissolved in microinjection buffer (5 mM sodium phosphate [pH 7.2] and 100 mM KCl). Sodium azide in the antibody preparation was removed by dialysis in three changes of microinjection buffer. Cells were transferred into fresh medium and allowed to recover for 60 to 90 min following injection of peptide (5 mg/ml) or antibody (0.2 mg/ml), prior to stimulation with insulin (100 nM) and analysis of GLUT4 translocation by the PM lawn assay.

PM lawn assay. GLUT4 translocation was determined by the PM lawn assay as described by Robinson and James (46) with modifications described by Marsh et al. (37). Briefly, 3T3-L1 cells grown on coverslips were washed in poly-L-lysine after cell treatment, hypotonically shocked with three washes in one-third intracellular buffer (70 mM KCl, 5 mM MgCl2, 3 mM EGTA, 1 mM dithiothreitol, 30 mM HEPES, pH 7.2), and sonicated with a probe sonicator (Microson, Farmington, N.Y.) at setting 0 in intracellular buffer to generate a lawn of PM fragments that remained attached to the coverslip. The fragments were then immunolabeled with rabbit anti-GLUT4 antibodies (R1159) (27) and Cy3-labeled goat anti-rabbit antibodies (Amersham, Little Chalfont, United Kingdom). Coverslips were visualized and imaged with a Bio-Rad Lasersharp MRC-500 confocal laser scanning immunofluorescence microscope. GLUT4 translocation in microinjected cells was compared to that in noninjected cells in the immediate vicinity on the same coverslip. Data was analyzed with Bio-Rad COMOS confocal imaging software. Six or more fields were analyzed for each condition within each experiment.

Treatment of cells, metabolic labeling, and preparation of extracts. Differentiated 3T3-L1 adipocytes were serum starved by incubating them in Krebs-Ringer phosphate buffer (KRP) containing 12.5 mM HEPES (pH 7.4), 120 mM NaCl, 6 mM KCl, 1.2 mM Mg2SO4, 1 mM CaCl2, 1 mM NaPO4, and 0.1% (wt/vol) BSA for at least 2 h at 37°C prior to stimulation. Insulin (1 µM; Eli Lilly) and PDGF (50 ng/ml; Gibco) treatments were for 5 or 15 min. Where indicated, 100 nM wortmannin (Sigma) was added to KRP 25 min prior to addition of insulin. For metabolic labeling, cells were incubated in low (0.2 mM)-phosphate KRP containing 0.5 mCi of 32Pi (ICN) per ml in place of the KRP incubation and then treated as described above. After treatment, cells were washed three times with ice-cold HES buffer (20 mM HEPES [pH 7.4], 1 mM EDTA, 250 mM sucrose) and homogenized in HES buffer supplemented with protease inhibitors (10 µg of aprotinin per ml, 10 µg of leupeptin per ml, and 1 mM phenylmethylsulfonyl fluoride) and phosphatase inhibitors (1 mM sodium orthovanadate, 1 mM sodium pyrophosphate, 1 mM ammonium molybdate, and 10 mM sodium fluoride) by 15 passes through a 22-gauge needle. 3T3-L1 fibroblasts were harvested in the same manner, except that homogenization was done through a 27-gauge needle. Subcellular fractionation of 3T3-L1 adipocytes was performed as described in the work of Clark et al. (16).

Preparation of primary rat adipocytes. Primary rat adipocytes were prepared from epididymal fat pads of male Wistar rats (100 to 125 g) by the collagenase digestion method (49). After incubation in KRP (containing 2% BSA) with agitation for 1 h at 37°C, cells were treated with or without 1 µM insulin for 15 min. Adipocytes were collected by centrifugation and homogenized in HES buffer with inhibitors by 15 passes through a 27-gauge needle.

Immunoprecipitation. Cells were harvested in lysis buffer (50 mM Tris [pH 7.5], 100 mM NaCl, 1% Triton X-100, 25 mM beta -glycerophosphate, protease inhibitors, and phosphatase inhibitors) and homogenized by 15 passes through a 22-gauge needle. After incubation on ice for 15 min, lysates were centrifuged at 12,800 × g for 15 min at 4°C. Immunoprecipitation was performed by adding the supernatants to Eppendorf tubes containing blocked, antibody-conjugated protein A-G beads (Pierce) and incubating them at 4°C with mixing for at least 2 h. Immunocomplexes were collected by centrifugation and washed twice with cold lysis buffer and once with low-salt buffer (10 mM NaCl, 10 mM Tris, pH 7.5). Proteins bound were eluted by addition of gel sample buffer.

To characterize PKB antibodies and for PKBbeta immunodepletion experiments, immunoprecipitation was performed by adding 100 µg of cell lysate (in HES buffer) to radioimmunoprecipitation assay buffer (150 mM NaCl, 10 mM Tris [pH 8], 1% Triton X-100, 1% sodium deoxycholate, and 0.1% sodium dodecyl sulfate [SDS]) supplemented with protease inhibitors and phosphatase inhibitors and incubating the lysate with antibody-conjugated protein A-G beads at 4°C. For PKBbeta depletion experiments, the supernatants were subjected to a second round of immunoprecipitation. To analyze the lysate after PKBbeta depletion, an aliquot of the supernatant after immunoprecipitation was subjected to methanol-chloroform precipitation (7). The resulting protein pellets were resuspended in Laemmli sample buffer and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE).

Electrophoresis and immunoblotting. Protein assays were performed using the Bradford assay reagent (Bio-Rad) or the bicinchoninic acid protein assay kit (Pierce), with BSA (fraction V; Pierce) as standard. SDS-PAGE was performed according to the method of Laemmli (34), using the SE400 system (Hoefer).

Two-dimensional gel electrophoresis (2-DE) with immobilized pH gradients was performed exactly as described in the work of Hill et al. (24), with nonlinear pH 3 to 10 immobilized pH gradients in the first dimension and SDS-7.5% PAGE gels in the second dimension. To prepare samples for 2-DE, cell lysates in HES buffer were precipitated with 4 volumes of methanol at -20°C for 1 h and then centrifuged for 10 min at 10,000 × g at room temperature. After the supernatants were removed, the pellets were air dried and resolubilized in 2D sample buffer (7 M urea, 2 M thiourea, 40 mM Tris, 4.4% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate [CHAPS], 84 mM dithiothreitol, 1% Pharmalyte, 0.01% bromophenol blue, 1 mM phenylmethylsulfonyl fluoride, and phosphatase inhibitors as described above). Samples were sonicated in a sonicating water bath (Branson) for 1 min at room temperature and then centrifuged as before. The resulting supernatants were underlaid into oil-filled sample cups positioned at the anode, and isoelectric point focusing was performed for 53.5 kV · h at 20°C.

After electrophoresis, proteins were transferred onto polyvinylidene difluoride membranes (Immobilon-P from Millipore) according to the method of Towbin et al. (56). Membranes were blocked in 5% skim milk powder in Tris-buffered saline-Tween (TBST; 50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Tween 20) for 1 h at room temperature and then incubated with the relevant primary antibody (diluted in blocking buffer or TBST) at 4°C overnight. After washing in TBST for 30 min with three changes of buffer, immunoreactive proteins were detected with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG), goat anti-mouse IgG (Amersham), or rabbit anti-sheep IgG (Sigma) as appropriate and SuperSignal chemiluminescence substrate (Pierce). Images were captured on film (Fuji) or a Lumi-Imager (Boehringer).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect of a PKB substrate peptide or a PKB antibody on insulin-stimulated GLUT4 translocation. Previous studies investigating the role of PKB in insulin-stimulated glucose transport have utilized overexpression of either constitutively active (18, 23, 30, 54, 57) or dominant negative (18, 23, 29, 32, 59) mutants of PKBalpha . These studies have produced conflicting results, and so we undertook a different approach to assess the role of PKB in insulin-stimulated glucose transport. Firstly, we have used microinjection in 3T3-L1 adipocytes. This approach circumvents potential adaptive responses that may occur during chronic overexpression of mutants, because we routinely perform our analysis 60 to 90 min after microinjection. This technique in combination with the PM lawn assay provides a means for examining the effects of inhibitors in single cells. Using this system, we routinely observe a 2.5-fold increase in cell surface levels of GLUT4 in response to insulin in cells microinjected with control peptides or control antibodies and in neighboring noninjected cells. Microinjection was performed with 3T3-L1 adipocytes with a peptide (KRPRAATF) closely related to the peptide previously determined to be relatively specific for PKB (1), except that a lysine was included at the N terminus to increase its solubility. As shown in Fig. 1A, the substrate peptide inhibited insulin-stimulated GLUT4 translocation by (66.1 ± 7.8)% (n = 10). A control peptide in which alanine was substituted for the phosphorylation site threonine had no significant effect on GLUT4 translocation ([7.3 ± 3.7]%, n = 6). This suggests that the injected substrate peptide is interfering with the propagation of the signaling pathway leading to GLUT4 translocation, probably by competing with a physiological substrate of PKB.


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 1.   Microinjection of PKB substrate peptide or an N-terminal PKB antibody inhibits insulin-stimulated GLUT4 translocation. 3T3-L1 adipocytes on coverslips were preincubated in Krebs-Ringer bicarbonate-HEPES buffer for 45 to 90 min. (A) Cells were then either not microinjected (Nil), microinjected with PKB substrate peptide (KRPRAATF), or microinjected with control peptide (KRPRAAAF) at 5 mg/ml. (B) 3T3-L1 adipocytes were either not injected (Nil) or microinjected with a purified N-terminal PKB antibody (PKB Ab) (N19; Santa Cruz) or purified rabbit IgG fraction (Control Ab) at 0.2 mg/ml. Bathing buffer was changed, and the cells were allowed to recover for 60 min. Cells were then stimulated or not with 100 nM insulin for 20 min prior to assessment of PM GLUT4 levels by the PM lawn assay as described in Materials and Methods. Results are from four or more experiments in which GLUT4 levels in six or more fields were determined for each condition within each experiment. *, P < 0.01 compared with insulin stimulation (paired t test).

To further assess the role of PKB in insulin-stimulated GLUT4 translocation, studies in which antibodies against PKB were microinjected into 3T3-L1 adipocytes were performed. An antibody directed against the N terminus of PKBalpha (N19 from Santa Cruz), which cross-reacts with PKBbeta , inhibited insulin-stimulated GLUT4 translocation by (55.6 ± 7.8)% whereas an unrelated antibody had no significant effect on this process (Fig. 1B). We also examined the effect of a variety of C-terminal PKB antibodies, including the isoform-specific sheep PKBbeta antibody described below. However, none of these antibodies had a significant effect on insulin-stimulated GLUT4 translocation in this system (data not shown). This may indicate that the C terminus is inaccessible in vivo or that antibody binding to this domain is less disruptive to PKB function.

Down-regulation of PDGF responsiveness in 3T3-L1 adipocytes. The microinjection data indicates that activation of PKB is necessary to fully mediate insulin-stimulated GLUT4 translocation in adipocytes. However, it has been reported that PDGF also activates PKB in adipocytes without any significant effect on GLUT4 translocation (10, 51, 54), raising the possibility that PKB activation may not be sufficient for insulin action. To explore this issue further, we have compared the effects of insulin with those of PDGF on the activation of PKB in 3T3-L1 adipocytes as well as their precursor cells, 3T3-L1 fibroblasts. As phosphorylation at Ser473 and Thr308 is essential for PKB activation, the effect of insulin and PDGF on PKB phosphorylation in 3T3-L1 cells was initially examined by immunoblotting with phosphospecific PKB antibodies (Fig. 2A). Treatment of 3T3-L1 fibroblasts with either insulin or PDGF for 15 min caused PKB phosphorylation on Ser473 and Thr308, with PDGF being more efficacious than insulin (Fig. 2A). The response to insulin compared with that to PDGF in 3T3-L1 adipocytes was quite different from that of fibroblasts. In this case, only insulin stimulated PKB phosphorylation, as detected by phosphospecific PKB antibodies (Fig. 2A).


View larger version (37K):
[in this window]
[in a new window]
  		FIG. 2.   Change in growth factor response accompanies differentiation of 3T3-L1 adipocytes. (A) Serum-starved 3T3-L1 fibroblasts or adipocytes were stimulated with 1 µM insulin (I) or 50 ng of PDGF per ml (P) for 15 min or left untreated (B). Cell lysates (30 µg) were analyzed by SDS-PAGE and immunoblotting with phospho-Ser473 (pSer473) or phospho-Thr308 (pThr308) PKB antibodies. (B) HA-PKBalpha or HA-PKBbeta was immunoprecipitated from lysates (100 µg) of 3T3-L1 fibroblasts expressing either HA-PKBalpha or HA-PKBbeta and analyzed by SDS-PAGE. Immunoblotting was performed with the sheep PKBalpha , the sheep PKBbeta , or the rabbit PKBbeta antibodies. (C) Cell lysates (30 µg) prepared as described for panel A were analyzed by SDS-PAGE and immunoblotting with the sheep PKBalpha or the sheep PKBbeta antibody. Bands labeled as band 1 exhibited the same electrophoretic mobility.

In order to correlate these results with phosphorylation of specific PKB isoforms, the isoform specificity of PKB antibodies was examined by immunoblotting using stable cell lines of 3T3-L1 fibroblasts expressing HA-tagged forms of PKBalpha or PKBbeta . HA-tagged PKB was immunoprecipitated from lysates with a monoclonal HA antibody and immunoblotted with a panel of PKB antibodies. The sheep PKBbeta antibody immunoblotted HA-PKBbeta but exhibited no detectable cross-reactivity with HA-PKBalpha (Fig. 2B). In contrast, the sheep PKBalpha antibody immunoblotted both HA-PKBalpha and HA-PKBbeta , and the rabbit PKBbeta antibody showed a slight cross-reactivity with HA-PKBalpha (Fig. 2B).

The above data suggests that the sheep PKBbeta antibody is isoform specific, at least in immunoblotting; however, the sheep PKBalpha antibody cross-reacts with PKBbeta to a considerable extent. Nevertheless, we proceeded to examine the relative expression and the effect of growth factors on the electrophoretic mobility of PKBalpha and PKBbeta by using the sheep PKB antibodies. As shown in Fig. 2C, both sheep PKBalpha and PKBbeta antibodies labeled bands in 3T3-L1 cells of an average molecular mass of 60 kDa, consistent with the calculated molecular mass of 56 kDa. While a single immunoreactive band was detected in basal fibroblasts, an additional band with lower molecular mass (band 0) was detected in basal adipocytes, with either the PKBalpha or the PKBbeta antibody (Fig. 2C). The band labeled with the PKBbeta antibody was up-regulated during the differentiation process whereas the intensity of the band labeled by the PKBalpha antibody in fibroblasts was not significantly different from the combined intensity of the two bands in adipocytes (Fig. 2C). In agreement with results presented in Fig. 2A, both insulin and PDGF caused an electrophoretic mobility shift in PKB in fibroblasts, whereas only insulin caused a shift in adipocytes. Interestingly, the electrophoretic shift for both PKBalpha and PKBbeta was much more pronounced in adipocytes than in fibroblasts. Moreover, in insulin-treated adipocytes, band 0 was almost quantitatively shifted to a position slightly above band 1 (labeled band 2) whereas the apparent mobility and intensity of band 1 were unchanged (Fig. 2C).

PKBbeta is highly up-regulated during adipocyte differentiation. Key molecules mediating insulin regulation of metabolism are increased upon adipocyte differentiation. Thus, we further examined the change in PKBbeta expression during the differentiation process and found that the increase in PKBbeta expression during differentiation closely paralleled that observed for GLUT4 (Fig. 3A). The most dramatic increase in both PKBbeta and GLUT4 occurred after day 6, when the differentiation medium was removed and cells were fed with medium supplemented only with 10% FCS (Fig. 3A). No GLUT4 expression was detected prior to initiation of differentiation (day 0, Fig. 3A). However, a low level of PKBbeta was detected (day 0, Fig. 3A). Preliminary experiments suggested that there may be changes in PKBbeta expression associated with cell confluency. This possibility was examined by immunoblotting lysates harvested from 3T3-L1 fibroblasts at different confluencies. As shown in Fig. 3B, no PKBbeta was detected in fibroblasts at 50% confluence, but a low level of expression was observed when 3T3-L1 fibroblasts reached confluence. Differentiation into adipocytes, however, induced a much more significant up-regulation of PKBbeta expression (Fig. 3B).


View larger version (22K):
[in this window]
[in a new window]
  		FIG. 3.   PKBbeta expression is induced upon adipocyte differentiation. (A) 3T3-L1 cells were harvested on each day of the differentiation procedure and analyzed for the expression of PKBbeta () or GLUT4 (open circle ) by immunoblotting with the sheep PKBbeta antibody or a rabbit anti-GLUT4 antibody (R017), respectively. Immunoreactive signal (obtained as Lumi-Imager units) was adjusted for total protein obtained per sample and then expressed as a percentage of the maximum. Results are representative of two separate experiments. (B) 3T3-L1 fibroblasts were harvested at subconfluence (50% or 90%) or 1 day after reaching confluence (post-conf.). 3T3-L1 adipocytes were harvested after completion of differentiation, at day 8 (adip). Cell lysates (30 µg) were analyzed for the level of PKBbeta expression by SDS-PAGE and immunoblotting with the sheep PKBbeta antibody.

PKBalpha is down-regulated in adipocytes. The above data clearly demonstrates an induction of PKBbeta expression during adipocyte differentiation. However, while PKBalpha appears to be highly expressed in fibroblasts, its expression in adipocytes is not clear due to antibody cross-reactivity. Thus, to more clearly determine PKBalpha expression, we performed immunoblotting on cell lysates that had been depleted of PKBbeta with the specific sheep PKBbeta antibody. In agreement with Fig. 2C, prior to PKBbeta immunodepletion, the PKBalpha antibody detected bands with similar intensities in fibroblasts and adipocytes, while a substantial induction of PKBbeta was observed in adipocytes (Fig. 4A). After immunodepletion with the sheep PKBbeta antibody, almost all of the immunoreactive PKBbeta was removed from the adipocyte lysate (Fig. 4A). When the same samples were immunoblotted with the PKBalpha antibody, there was little difference in the fibroblasts before and after PKBbeta immunodepletion, suggesting that PKBalpha is expressed at high levels in fibroblasts. However, there was a substantial reduction in immunolabeling with this antibody in adipocytes after PKBbeta depletion, suggesting that most of the PKBalpha immunoreactivity is due to PKBbeta in these cells and that PKBbeta is the predominant isoform expressed in 3T3-L1 adipocytes (Fig. 4A). To determine if this is a general feature of adipocytes, we performed similar experiments with primary cultures of adipocytes isolated from rat fat. Prior to PKBbeta immunodepletion, both the PKBalpha and the PKBbeta antibodies detected a band which showed an electrophoretic mobility shift with insulin treatment (Fig. 4B). However, after PKBbeta depletion, no PKBalpha was detected in rat adipocyte lysates, suggesting that these cells do not express significant levels of PKBalpha (Fig. 4B).


View larger version (31K):
[in this window]
[in a new window]
  		FIG. 4.   PKBbeta is the predominant isoform in adipocytes. (A) Cell lysates (100 µg) from serum-starved 3T3-L1 fibroblasts (Fib) or 3T3-L1 adipocytes (Ad) were depleted of PKBbeta by two consecutive rounds of immunoprecipitation with the sheep PKBbeta antibody. Twenty micrograms of lysate (Lysate) and one-fifth of the immunoprecipitation supernatant (After PKBbeta -IP) were analyzed by SDS-PAGE and immunoblotting with the sheep PKBalpha or the sheep PKBbeta antibodies. (B) Cell lysates (100 µg) from isolated rat adipocytes treated with 1 µM insulin (I) for 15 min or left basal (B) were depleted of PKBbeta and analyzed as described for panel A. (C) Immunoprecipitation with the sheep PKBbeta antibody was performed on 100 µg of cell lysates prepared from 3T3-L1 adipocytes overexpressing HA-PKBalpha . The immunoprecipitate (PKBbeta -IP) and 10 µg of lysate (Lysate) were analyzed by SDS-PAGE and immunoblotting for the presence of HA-PKBalpha , with a monoclonal HA antibody.

One trivial explanation for these observations is that PKBalpha and PKBbeta hetero-oligomerize and therefore all of the PKBalpha is removed during PKBbeta immunodepletion. However, this seems unlikely because interaction between PKB molecules has been shown to be isoform specific, as the Akt homology domain of PKBalpha coimmunoprecipitates PKBalpha but not PKBbeta (21). Nevertheless, we addressed this possibility using 3T3-L1 adipocytes overexpressing HA-PKBalpha . As shown in Fig. 4C, no signal corresponding to HA-PKBalpha was detected in the PKBbeta immunoprecipitate, demonstrating that, under these conditions, PKBalpha does not coimmunoprecipitate with PKBbeta .

Insulin but not PDGF stimulates PKBbeta phosphorylation in 3T3-L1 adipocytes. The above data suggests that PKBbeta is the most pertinent isoform for the insulin-specific PKB phosphorylation in 3T3-L1 adipocytes observed in Fig. 2A. To verify this conclusion, we next examined the phosphorylation of PKB isoforms following immunoprecipitation with isoform-specific antibodies. To examine the extent of PKBalpha phosphorylation, it was necessary to first deplete lysates of PKBbeta prior to immunoprecipitation with the PKBalpha antibody. In these experiments, we also examined the effect of insulin and PDGF after 5 min of stimulation, in order to assess if PDGF has a transient effect on PKB activity. Insulin, but not PDGF, stimulated the phosphorylation of immunoprecipitated PKBalpha in 3T3-L1 adipocytes as detected by phospho-PKB antibodies (Fig. 5A). However, this signal most likely represents residual PKBbeta that was immunoprecipitated by the PKBalpha antibody (Fig. 5A). A marked increase in PKBbeta phosphorylation was observed in response to insulin, while PDGF had little effect on PKBbeta phosphorylation at 5 or 15 min of stimulation (Fig. 5A). PKBbeta phosphorylation was also directly examined by immunoprecipitation from 3T3-L1 adipocytes metabolically labeled with 32P (Fig. 5B). A low level of constitutive phosphorylation was observed under basal conditions, and insulin stimulation caused a threefold increase in PKBbeta phosphorylation (Fig. 5B). Insulin-stimulated phosphorylation was accompanied by an electrophoretic mobility shift, and the shifted band was specifically detected by phospho-Ser473 PKB antibodies (Fig. 5B). In agreement with previous results (Fig. 2 and 5A), PDGF had no significant effect on PKBbeta phosphorylation in 3T3-L1 adipocytes.


View larger version (43K):
[in this window]
[in a new window]
  		FIG. 5.   Insulin but not PDGF stimulates phosphorylation of PKBbeta in 3T3-L1 adipocytes. (A) PKB isoforms were immunoprecipitated from 100 µg of 3T3-L1 lysates prepared from unstimulated cells (B) or cells treated with 1 µM insulin (I) or 50 ng of PDGF per ml (P) for 5 or 15 min. In the case of the PKBalpha immunoprecipitation, PKBbeta was first depleted from the cell lysate by two consecutive rounds of immunoprecipitation. Immunoprecipitates were analyzed by SDS-PAGE and immunoblotting with phospho-Ser473 (pSer473) or phospho-Thr308 (pThr308) PKB antibodies or the sheep PKBbeta antibody (PKBbeta ). (B) PKBbeta was immunoprecipitated from 32P-labeled 3T3-L1 adipocytes treated with 1 µM insulin (I) or 50 ng of PDGF per ml (P) for 15 or left basal (B), by using the sheep PKBbeta antibody, and analyzed by SDS-PAGE. The polyvinylidene difluoride membrane was subjected to autoradiography (autorad.) and then immunoblotted with the phospho-Ser473 antibody (pSer473).

2-DE was used to further examine PKBbeta phosphorylation in adipocytes. PKBbeta was immunoprecipitated from 32P-labeled 3T3-L1 adipocytes and then subjected to 2-DE and autoradiography. Two spots of similar molecular masses but different pIs were detected in basal adipocytes (spots 1 and 2, Fig. 6A). The observed pI of these phosphospots was 5.6 to 5.8, which agrees with that calculated for PKBbeta (5.9). The presence of the two phospho-PKBbeta spots is consistent with two sites of constitutive phosphorylation, where spots 1 and 2 represent mono- and dual-phosphorylated forms, respectively. Insulin stimulation resulted in an increase in the intensity of spots 1 and 2, as well as the 32P labeling of an additional spot (spot 3) of more acidic pI (Fig. 6B). To determine the relative abundance of differentially phosphorylated forms of PKBbeta , we performed 2D immunoblotting. In addition to spots 1 and 2, a spot at pI 6 in 2D blots of basal adipocyte lysate which represents unphosphorylated PKBbeta was detected (spot 0, Fig. 6C). A close examination of Fig. 6C shows that, under basal conditions, the majority of PKBbeta is either unphosphorylated (spot 0) or monophosphorylated (spot 1), with only a minor proportion being dual phosphorylated (spot 2). Insulin stimulation caused the complete disappearance of spot 0 with a significant increase in the intensity of spot 2 and the appearance of spot 3 (Fig. 6D). The effect of PDGF stimulation on the 2D pattern of PKBbeta spots was also examined. Consistent with previous results (Fig. 2 and 5), stimulation of 3T3-L1 adipocytes with 50 ng of PDGF per ml for 15 min did not result in the leftward shift of 2D PKBbeta spots observed in response to insulin (compare Fig. 6C to E). In addition, pretreatment of cells with 100 nM wortmannin completely inhibited the insulin effect on the PKBbeta 2D pattern (Fig. 6F), consistent with the reported PI3K dependence of insulin-stimulated PKB activation.


View larger version (33K):
[in this window]
[in a new window]
  		FIG. 6.   Analysis of insulin-stimulated PKBbeta phosphorylation in 3T3-L1 adipocytes by 2-DE. 3T3-L1 adipocytes were 32P labeled and then stimulated without (A) or with (B) 1 µM insulin for 15 min. PKBbeta was immunoprecipitated from cell lysates by using the rabbit anti-PKBbeta antibody and analyzed by 2-DE and autoradiography. Lysates (150 µg) prepared from untreated 3T3-L1 adipocytes (C) or adipocytes treated with 1 µM insulin for 15 min (D), 50 ng of PDGF per ml for 15 min (E), or 100 nM wortmannin for 40 min with 1 µM insulin added for the last 15 min (F) were analyzed by 2-DE and immunoblotting with the rabbit anti-PKBbeta antibody. Immunoblots of the polyvinylidene difluoride membranes from panels A and B yielded results similar to those for panels C and D.

Insulin stimulates PKBbeta translocation to the PM and HDM fractions. Apart from phosphorylation, membrane translocation is thought to be required for activation of PKB. The current model of PKB activation suggests that PKB is recruited to the PM via its pleckstrin homology domain by the 3'-phosphoinositides generated by the receptor-activated PI3K, where it is phosphorylated at Ser473 and Thr308 by 3'-phosphoinositide-dependent kinase 1 (PDK1) and PDK2 (reviewed in references 2 and 40). We and others have previously reported that insulin and PDGF stimulate PI3K in adipocytes but that the subcellular distribution of the enzyme is different in each case (16, 41, 45). With PDGF, we observed a significant increase in PI3K activity in the PM fraction, whereas with insulin, it was enriched in a high-speed pellet (HSP) fraction associated with IRS-1 and/or -2 (16). Thus, we next studied the distribution of PKBbeta among these fractions. Under basal conditions, almost all the immunoreactive PKBbeta was found in the cytosol (Fig. 7). In agreement with previous results, basal PKBbeta in the cytosol fraction was resolved into two bands, corresponding to bands 0 and 1 in Fig. 2A. A band detected in the HSP fraction in the basal state exhibited apparent electrophoretic mobility similar to that of band 0; however, in contrast to bands in the cytosol, insulin did not induce an electrophoretic mobility shift of the HSP band (Fig. 7). Insulin induced the translocation of PKBbeta to the PM and high-density microsome (HDM) fractions, while PDGF was without effect. This translocation does not represent the association of PKBbeta with large protein complexes because we find that it floats up through sucrose upon sedimentation, consistent with a membrane-associated protein (data not shown). Insulin-stimulated translocation of PKBbeta was restricted to band 2, the activated form of PKBbeta , as confirmed by immunoreactivity to the phospho-Ser473 PKB antibody (Fig. 7). Interestingly, PKBbeta in the cytosol fraction underwent an almost quantitative shift from band 0 to band 2 within 5 min of insulin stimulation, coincident with increased Ser474 phosphorylation (Fig. 7). This suggests that either PKBbeta was activated in the cytosol or it is activated at the PM and rapidly translocates from this site to the cytosol.


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 7.   Insulin, but not PDGF, stimulates the translocation of PKBbeta to membrane fractions in 3T3-L1 adipocytes. 3T3-L1 adipocytes were stimulated with insulin (I) or PDGF (P) for 5 or 15 min or left basal (B). Cells were homogenized and subfractionated by differential centrifugation as described in Materials and Methods, to generate the PM, HDM, HSP (also termed LDM), cytosol (CYT), and the mitochondrial-nuclear (M/N) fractions. Twenty micrograms of each fraction was analyzed by SDS-PAGE and immunoblotting with the sheep PKBbeta (PKBbeta ) or the phospho-Ser473 PKB (pSer473) antibody.

Recent studies reporting the insulin-induced association of PKBbeta with GLUT4-containing vesicles (12) and phosphorylation of its components (33) suggest that PKBbeta may directly mediate GLUT4 translocation. In contrast to the report by Calera et al. (12) for rat adipocytes, we did not detect PKBbeta in membrane fractions in the basal state, nor did we observe significant insulin-induced translocation of PKBbeta to the HSP fraction (also termed the low-density microsome [LDM] fraction) in 3T3-L1 adipocytes (Fig. 7). To further assess if PKBbeta directly interacts with GLUT4 vesicles, we examined the ability of insulin or PDGF to stimulate GLUT4 translocation in 3T3-L1 fibroblasts overexpressing both GLUT4 and PKBbeta . Activation of PKBbeta by either insulin or PDGF did not alter the subcellular location of GLUT4 in these cells (data not shown), suggesting that activation of PKBbeta is not sufficient to stimulate GLUT4 translocation in this system.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In the present study, we have provided further evidence to support a role for the serine/threonine kinase PKB in insulin-stimulated glucose transport in adipocytes. We show that a PKB substrate peptide or an antibody to PKB inhibited insulin-stimulated GLUT4 translocation by 66 and 56%, respectively. Moreover, we have obtained evidence to implicate the PKBbeta isoform in insulin action: (i) the expression of PKBbeta is substantially increased during adipocyte differentiation whereas the expression of PKBalpha is markedly reduced during this process, (ii) primary cultures of rat adipocytes have no detectable immunoreactive PKBalpha , and (iii) insulin but not PDGF stimulates PKBbeta phosphorylation and translocation to membranes in 3T3-L1 adipocytes.

Previous studies have reported contradictory findings concerning the role of PKB in insulin-stimulated glucose transport (18, 23, 29, 30, 32, 54, 57, 59). We believe the present study provides strong support for the involvement of PKB in insulin action and clarifies some potential areas of contradiction that have arisen. First, as discussed in more detail below, our study implicates a role only for PKBbeta and not for PKBalpha in insulin regulation of glucose transport in adipocytes. This may be critical, as many previous studies have used reagents that either specifically target PKBalpha or, as a minimum, have questionable specificity for different PKB isoforms. Second, we have employed a strategy involving microinjection of either antibodies or substrate peptides and then examination of the consequences of these reagents for GLUT4 trafficking 60 to 90 min later. This likely overcomes potential cellular adaptive mechanisms which could occur in response to expression of cDNAs over a much longer time course.

Role of PKBalpha versus PKBbeta . Initial comparison of the relative expression of PKBalpha and PKBbeta in 3T3-L1 fibroblasts with that in adipocytes by immunoblotting suggested that, while PKBbeta was up-regulated, PKBalpha expression was not significantly altered by adipocyte differentiation (Fig. 2C). However, as the PKBalpha antibody was found to cross-react with PKBbeta (Fig. 2B), part of the PKBalpha immunoreactivity in 3T3-L1 adipocytes likely represented PKBbeta , which is highly expressed in these cells. We tested this hypothesis by depleting PKBbeta from cell lysates prior to immunoblotting with the PKBalpha antibody and found that, indeed, most of the PKBalpha immunoreactivity in adipocytes was removed by PKBbeta depletion (Fig. 4A). In contrast, substantial PKBalpha immunoreactivity remained after PKBbeta depletion of fibroblast lysates (Fig. 4A). Consistent with our findings in 3T3-L1 adipocytes, we also find that there is very little PKBalpha in rat adipocytes, with PKBbeta being the major isoform (Fig. 4B). Based on the present studies, we predict that previous reports of insulin-activated PKBalpha activity in rat adipocytes may be due to antibody cross-reactivity.

These results suggest that there is a switch in isoform expression during differentiation of fibroblasts into adipocytes. As PKBalpha and PKBbeta are 81% identical in amino acid sequence, the specific change in isoform expression upon adipocyte differentiation is likely to be functional. Fibroblasts represent a highly proliferative cell type, and so it seems likely that PKBalpha is important in the regulation of cell growth and proliferation, and its down-regulation upon differentiation is appropriate as adipocytes are terminally differentiated and not proliferative. On the other hand, the induction of PKBbeta expression during adipocyte differentiation parallels that observed for GLUT4 (Fig. 3A), implying a role for PKBbeta in metabolic regulation in adipocytes. Further support comes from our observation that rat adipocytes express high levels of PKBbeta (Fig. 4B) and from the reported high PKBbeta mRNA expression in brown adipose tissue (3). An induction of PKBbeta mRNA was also observed upon differentiation of Sol8 muscle cells (13) and C2C12 myotubes (3), supporting a role for PKBbeta in insulin regulation of metabolism in muscle cells in addition to adipocytes. In our study, no PKBbeta expression was observed in subconfluent, highly proliferative fibroblasts. A slight increase in PKBbeta expression was observed when cells became confluent in culture, followed by a more dramatic induction when fibroblasts differentiated into adipocytes (Fig. 3). Taken together, these observations suggest that the expression of PKBbeta is normally restricted to terminally differentiated, nonproliferative cells, where PKBbeta plays a role in metabolic regulation. The inappropriate expression of PKBbeta in undifferentiated cells can lead to uncontrolled cell proliferation as demonstrated by the transforming ability of PKBbeta when overexpressed in NIH 3T3 cells (15). Overexpression of constitutively active PKBalpha in 3T3-L1 fibroblasts leads to spontaneous differentiation into adipocytes (36). To further address the roles of different PKB isoforms, it may be of interest to compare the effects of overexpressing constitutively active PKBbeta or PKBgamma to that observed for PKBalpha in 3T3-L1 fibroblasts.

Activation of PKBbeta is insulin specific in 3T3-L1 adipocytes. Several recent studies have compared the signaling of insulin with that of PDGF in adipocytes, based on the hypothesis that the inability of PDGF to induce glucose uptake reflects its inability to activate a relevant downstream signaling pathway(s). Indeed, several groups have reported differences between the subcellular location of PI3K activated by insulin and that of PI3K activated by PDGF (16, 41, 45). Furthermore, PDGF was found to have little effect on the levels of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in 3T3-L1 adipocytes, whereas insulin induced a significant increase (19). These results suggest that, while PI3K is activated by recruitment to activated PDGF receptors at the PM in 3T3-L1 adipocytes, it may not have access to appropriate substrates and thus is unable to produce a rise in PIP3. In agreement with the lack of PDGF-induced PIP3 production, we found no effect of PDGF on PKBbeta phosphorylation in 3T3-L1 adipocytes by electrophoretic mobility shift, immunoprecipitation in conjunction with 32P labeling or immunoblotting with phosphospecific antibodies, or isoelectric point shifts analyzed by 2-DE. Furthermore, PDGF did not stimulate membrane translocation of PKBbeta , as observed with insulin, nor did it have a transient effect on PKBbeta phosphorylation (Fig. 5A). The insulin specificity further supports a role for PKBbeta in the regulation of glucose metabolism in adipocytes.

Three previous studies have reported variable effects of PDGF on PKB in 3T3-L1 adipocytes (10, 51, 54). Two studies utilized phospho-Ser473 PKB antibodies and found a small PDGF-induced PKB phosphorylation (~20% of insulin effect). We were unable to detect PDGF-stimulated PKB phosphorylation in 3T3-L1 adipocytes treated with 50 ng of PDGF per ml with the same antibody in immunoblotting of cell lysates (Fig. 2A), but very weak PDGF-induced PKBbeta phosphorylation was sometimes observed in immunoprecipitates (Fig. 5A). Tanti et al. observed a significant PDGF-stimulated activation of PKB (to 50% of the insulin effect) in 3T3-L1 adipocytes by immunoprecipitation-coupled kinase assays (54). The reason for the discrepancy between these studies is not clear. One possible explanation is differences in the integrity of 3T3-L1 adipocyte cultures. As PKBalpha is the predominant isoform in 3T3-L1 fibroblasts and is strongly activated by PDGF in these cells, an increased level of fibroblast contamination of adipocyte cultures may give rise to a PDGF response on PKB. This may be further amplified in the case of immunoprecipitation with an antibody with a high affinity for PKBalpha .

Regulation of PKBbeta activation in 3T3-L1 adipocytes. A synthesis of our data concerning activation of PKBbeta in 3T3-L1 adipocytes suggests that both unphosphorylated (band 0 and spots 0) and phosphorylated (band 1 and spots 1 and 2) PKBbeta are present in basal adipocytes. Furthermore, separation of phospho-PKB into two spots with different pI suggests that there are two populations of differentially phosphorylated forms of PKBbeta in basal 3T3-L1 adipocytes. Constitutive phosphorylation of PKBbeta in 3T3-L1 adipocytes does not occur on either Ser474 or Thr309, because no significant signal was detected with phospho-PKB antibodies in basal adipocytes (Fig. 2A and 5A). Two constitutive phosphorylation sites have been reported for PKBbeta transfected into HEK-293 cells, and these are Ser125 and Thr451 (39). Thus one interpretation of our results is that ~50% of PKBbeta is constitutively phosphorylated, possibly on either Ser125 or Thr451 in the basal state in 3T3-L1 adipocytes (spot 1), while a small amount is dual phosphorylated on both residues, resulting in a more acidic pI (spot 2). Insulin caused the total disappearance of nonphosphorylated PKBbeta (spot 0), with an increase in the immunoreactivity of spots 2 and 3, concomitant with insulin-induced phosphorylation (Fig. 6A to D). A recent study suggests that constitutive phosphorylation at Thr450 primers PKBalpha for subsequent growth factor stimulation when expressed in NIH 3T3 cells (9). Thus, one possibility is that insulin stimulates phosphorylation of basally unphosphorylated PKBbeta (spot 0) on one or both of the constitutive sites (Ser125 and Thr451) but that only basally phosphorylated PKBbeta (spots 1 and 2) becomes phosphorylated on activating sites (Ser474 and Thr309). As the present data does not provide information on the sites of phosphorylation of the differentially charged PKBbeta isoforms, further investigation is required to confirm this hypothesis in 3T3-L1 adipocytes. Interestingly, only a single band which exhibits an electrophoretic mobility that is intermediate between bands 0 and 1 was observed in rat adipocytes. Upon insulin stimulation, the entire band shifts to a position corresponding to band 2. The phosphorylation state of the basal band in rat adipocytes is yet to be determined and should provide valuable data on the role of constitutive phosphorylation.

Current models of growth factor-stimulated PKB activation suggest that the products of PI3K recruit both PDK1 and PKB to the PM, where PDK1 phosphorylates and activates PKB (2, 4, 40). The requirement for membrane translocation in PKB activation is supported by the finding that forced translocation to the PM by myristoylation-palmitylation is sufficient to induce PKB phosphorylation at Thr308 and Ser473 (5). In the present study, we observed specific translocation of phosphorylated PKBbeta to the PM and HDM fractions in response to insulin treatment of 3T3-L1 adipocytes. In agreement with the inability of PDGF to induce PKBbeta phosphorylation, no membrane translocation was observed in response to PDGF stimulation. Interestingly, while some PKBbeta remained associated with the PM and the HDM, a major portion of activated PKBbeta was observed in the cytosol within 5 min of insulin stimulation (Fig. 7). These results suggest that either PKBbeta can be activated in the cytosol or, more likely, following activation at the membrane, most PKBbeta returns to the cytosol where it is able to phosphorylate its physiological substrates. Recent reports of insulin-induced association of PKBbeta with GLUT4-containing vesicles (12) and phosphorylation of its components (33) suggest that PKBbeta may directly regulate the GLUT4 translocation machinery. We did not observe any significant recruitment of PKBbeta to the HSP-LDM fraction which contains the insulin-responsive pool of GLUT4 in 3T3-L1 adipocytes. However, it is possible that our assay is not sensitive enough to detect a low level of PKBbeta recruitment to this fraction. Thus, we further tested the hypothesis that PKBbeta directly mediates GLUT4 translocation by examining the effect of activating PKBbeta by insulin or PDGF in 3T3-L1 fibroblasts expressing both PKBbeta and GLUT4. Neither insulin nor PDGF stimulated GLUT4 translocation in these cells, suggesting that either another signaling pathway is required or fibroblasts lack the expression of downstream signaling molecules or machinery required for GLUT4 translocation.

In summary, our data implicates an important role for PKB in insulin action in adipocytes. We cannot exclude a role for alternate parallel pathways such as PKClambda and/or PKCzeta . Using microinjection of either a PKB substrate peptide or a PKB antibody, we observed a ~60% inhibition of insulin-stimulated GLUT4 translocation to the PM. Hence, it is conceivable that the residual insulin action is due to a PKB-independent pathway. Further effort is required to identify this alternate pathway and to identify downstream targets of PKBbeta in adipocytes.


    ACKNOWLEDGMENTS

The first two authors contributed equally to this paper.

This work was supported by grants from the National Health and Medical Research Council of Australia and the Juvenile Diabetes Foundation International. D.E.J. is an NHMRC Principal Research Fellow. CMCB is a Special Research Centre of the Australian Research Council.

We thank Laura Martin, Ning-Xia Fang, Timo Meerloo, and Teresa Munchow for technical assistance and Emme Lin for discussions on the microinjection studies.


    FOOTNOTES

* Corresponding author. Mailing address: Centre for Molecular and Cellular Biology and Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia. Phone: 61 7 3365 4986. Fax: 61 7 3365 4388. E-mail: D.James{at}cmcb.uq.edu.au.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Alessi, D. R., F. B. Caudwell, M. Andjelkovic, B. A. Hemmings, and P. Cohen. 1996. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:333-338[Medline].
2. Alessi, D. R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8:55-62[Medline].
3. Altomare, D. A., G. E. Lyons, Y. Mitsuuchi, J. Q. Cheng, and J. R. Testa. 1998. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16:2407-2411[Medline].
4. Anderson, K. E., J. Coadwell, L. R. Stephens, and P. T. Hawkins. 1998. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr. Biol. 8:684-691[Medline].
5. Andjelkovic, M., D. R. Alessi, R. Meier, A. Fernandez, N. J. Lamb, M. Frech, P. Cron, P. Cohen, J. M. Lucocq, and B. A. Hemmings. 1997. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272:31515-31524[Abstract/Free Full Text].
6. Araki, E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. Haag, 3rd, R. S. Johnson, and C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190[Medline].
7. Arand, M., T. Friedberg, and F. Oesch. 1994. Monitoring sodium dodecyl sulfate contamination, p. 276-278. In J. E. Celis (ed.), Cell biology: a laboratory handbook, vol. 3. Academic Press, London, United Kingdom.
8. Bandyopadhyay, G., M. L. Standaert, L. Zhao, B. Yu, A. Avignon, L. Galloway, P. Karnam, J. Moscat, and R. V. Farese. 1997. Activation of protein kinase C (alpha , beta , and zeta ) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 272:2551-2558[Abstract/Free Full Text].
9. Bellacosa, A., T. O. Chan, N. N. Ahmed, K. Datta, S. Malstrom, D. Stokoe, F. McCormick, J. Feng, and P. Tsichlis. 1998. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17:313-325[Medline].
10. Brady, M. J., F. J. Bourbonais, and A. R. Saltiel. 1998. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells. J. Biol. Chem. 273:14063-14066[Abstract/Free Full Text].
11. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602[Medline].
12. Calera, M. R., C. Martinez, H. Liu, A. K. Jack, M. J. Birnbaum, and P. F. Pilch. 1998. Insulin increases the association of Akt-2 with Glut4-containing vesicles. J. Biol. Chem. 273:7201-7204[Abstract/Free Full Text].
13. Calera, M. R., and P. F. Pilch. 1998. Induction of akt-2 correlates with differentiation in sol8 muscle cells. Biochem. Biophys. Res. Commun. 251:835-841[Medline].
14. Cheatham, B., C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911[Abstract/Free Full Text].
15. Cheng, J. Q., D. A. Altomare, M. A. Klein, W. C. Lee, G. D. Kruh, N. A. Lissy, and J. R. Testa. 1997. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14:2793-2801[Medline].
16. Clark, S. F., S. Martin, A. J. Carozzi, M. M. Hill, and D. E. James. 1998. Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J. Cell Biol. 140:1211-1225[Abstract/Free Full Text].
17. Clarke, J. F., P. W. Young, K. Yonezawa, M. Kasuga, and G. D. Holman. 1994. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300:631-635.
18. Cong, L. N., H. Chen, Y. Li, L. Zhou, M. A. McGibbon, S. I. Taylor, and M. J. Quon. 1997. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol. Endocrinol. 11:1881-1890[Abstract/Free Full Text].
19. Conricode, K. M. 1995. Involvement of phosphatidylinositol 3-kinase in stimulation of glucose transport by growth factors in 3T3-L1 adipocytes. Biochem. Mol. Biol. Int. 36:835-843[Medline].
20. Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789[Medline].
21. Datta, K., T. F. Franke, T. O. Chan, A. Makris, S. I. Yang, D. R. Kaplan, D. K. Morrison, E. A. Golemis, and P. N. Tsichlis. 1995. AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol. Cell. Biol. 15:2304-2310[Abstract].
22. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736[Medline].
23. Hajduch, E., D. R. Alessi, B. A. Hemmings, and H. S. Hundal. 1998. Constitutive activation of protein kinase Balpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006-1013[Abstract].
24. Hill, M. M., S. F. Clark, and D. E. James. 1997. Insulin-regulatable phosphoproteins in 3T3-L1 adipocytes form detergent-insoluble complexes not associated with caveolin. Electrophoresis 18:2629-2637[Medline].
25. Hunter, S. J., and W. T. Garvey. 1998. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am. J. Med. 105:331-345[Medline].
26. James, D. E., M. Strube, and M. Mueckler. 1989. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338:83-87[Medline].
27. Kelada, A. S., S. L. Macaulay, and J. Proietto. 1992. Cyclic AMP acutely stimulates translocation of the major insulin-regulatable glucose transporter GLUT4. J. Biol. Chem. 267:7021-7025[Abstract/Free Full Text].
28. Kellerer, M., R. Lammers, and H. U. Haring. 1999. Insulin signal transduction: possible mechanisms for insulin resistance. Exp. Clin. Endocrinol. Diabetes 107:97-106[Medline].
29. Kitamura, T., W. Ogawa, H. Sakaue, Y. Hino, S. Kuroda, M. Takata, M. Matsumoto, T. Maeda, H. Konishi, U. Kikkawa, and M. Kasuga. 1998. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18:3708-3717[Abstract/Free Full Text].
30. Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271:31372-31378[Abstract/Free Full Text].
31. Kotani, K., A. J. Carozzi, H. Sakaue, K. Hara, L. J. Robinson, S. F. Clark, K. Yonezawa, D. E. James, and M. Kasuga. 1995. Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 209:343-348[Medline].
32. Kotani, K., W. Ogawa, M. Matsumoto, T. Kitamura, H. Sakaue, Y. Hino, K. Miyake, W. Sano, K. Akimoto, S. Ohno, and M. Kasuga. 1998. Requirement of atypical protein kinase Clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 18:6971-6982[Abstract/Free Full Text].
33. Kupriyanova, T. A., and K. V. Kandror. 1999. Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin. J. Biol. Chem. 274:1458-1464[Abstract/Free Full Text].
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline].
35. Macaulay, S. L., D. R. Hewish, K. H. Gough, V. Stoichevska, S. F. MacPherson, M. Jagadish, and C. W. Ward. 1997. Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation. Biochem. J. 324:217-224.
36. Magun, R., B. M. Burgering, P. J. Coffer, D. Pardasani, Y. Lin, J. Chabot, and A. Sorisky. 1996. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137:3590-3593[Abstract].
37. Marsh, B. J., R. A. Alm, S. R. McIntosh, and D. E. James. 1995. Molecular regulation of GLUT4 targeting in 3T3-L1 adipocytes. J. Cell Biol. 130:1081-1091[Abstract/Free Full Text].
38. Martin, S. S., T. Haruta, A. J. Morris, A. Klippel, L. T. Williams, and J. M. Olefsky. 1996. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 271:17605-17608[Abstract/Free Full Text].
39. Meier, R., D. R. Alessi, P. Cron, M. Andjelkovic, and B. A. Hemmings. 1997. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta . J. Biol. Chem. 272:30491-30497[Abstract/Free Full Text].
40. Meier, R., and B. A. Hemmings. 1999. Regulation of protein kinase B. J. Recept. Signal Transduct. Res. 19:121-128[Medline].
41. Nave, B. T., R. J. Haigh, A. C. Hayward, K. Siddle, and P. R. Shepherd. 1996. Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem. J. 318:55-60.
42. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573[Abstract/Free Full Text].
43. Quon, M. J., A. J. Butte, M. J. Zarnowski, G. Sesti, S. W. Cushman, and S. I. Taylor. 1994. Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. J. Biol. Chem. 269:27920-27924[Abstract/Free Full Text].
44. Rice, K. M., and C. W. Garner. 1994. Correlation of the insulin receptor substrate-1 with insulin-responsive deoxyglucose transport in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 198:523-530[Medline].
45. Ricort, J. M., J. F. Tanti, E. Van Obberghen, and Y. Le Marchand-Brustel. 1996. Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes. A possible explanation for their specific effects on glucose transport. Eur. J. Biochem. 239:17-22[Medline].
46. Robinson, L. J., and D. E. James. 1992. Insulin-regulated sorting of glucose transporters in 3T3-L1 adipocytes. Am. J. Physiol. 263:E383-393[Abstract/Free Full Text].
47. Sharma, P. M., K. Egawa, Y. Huang, J. L. Martin, I. Huvar, G. R. Boss, and J. M. Olefsky. 1998. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J. Biol. Chem. 273:18528-18537[Abstract/Free Full Text].
48. Shaw, M., P. Cohen, and D. R. Alessi. 1998. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336:241-246.
49. Simpson, I. A., D. R. Yver, P. J. Hissin, L. J. Wardzala, E. Karnieli, L. B. Salans, and S. W. Cushman. 1983. Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions. Biochim. Biophys. Acta 763:393-407[Medline].
50. Standaert, M. L., L. Galloway, P. Karnam, G. Bandyopadhyay, J. Moscat, and R. V. Farese. 1997. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272:30075-30082[Abstract/Free Full Text].
51. Staubs, P. A., J. G. Nelson, D. R. Reichart, and J. M. Olefsky. 1998. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J. Biol. Chem. 273:25139-25147[Abstract/Free Full Text].
52. Summers, S. A., E. L. Whiteman, H. Cho, L. Lipfert, and M. J. Birnbaum. 1999. Differentiation-dependent suppression of platelet-derived growth factor signaling in cultured adipocytes. J. Biol. Chem. 274:23858-23867[Abstract/Free Full Text].
53. Tanti, J. F., T. Gremeaux, S. Grillo, V. Calleja, A. Klippel, L. T. Williams, E. Van Obberghen, and Y. Le Marchand-Brustel. 1996. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J. Biol. Chem. 271:25227-25232[Abstract/Free Full Text].
54. Tanti, J. F., S. Grillo, T. Gremeaux, P. J. Coffer, E. Van Obberghen, and Y. Le Marchand-Brustel. 1997. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138:2005-2010[Abstract/Free Full Text].
55. Tordjman, K. M., K. A. Leingang, D. E. James, and M. M. Mueckler. 1989. Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment. Proc. Natl. Acad. Sci. USA 86:7761-7765[Abstract/Free Full Text].
56. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354[Abstract/Free Full Text].
57. Ueki, K., R. Yamamoto-Honda, Y. Kaburagi, T. Yamauchi, K. Tobe, B. M. Burgering, P. J. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273:5315-5322[Abstract/Free Full Text].
58. Walker, K. S., M. Deak, A. Paterson, K. Hudson, P. Cohen, and D. R. Alessi. 1998. Activation of protein kinase B beta  and gamma  isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha . Biochem. J. 331:299-308.
59. Wang, Q., R. Somwar, P. J. Bilan, Z. Liu, J. Jin, J. R. Woodgett, and A. Klip. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19:4008-4018[Abstract/Free Full Text].
60. Withers, D. J., J. S. Gutierrez, H. Towery, D. J. Burks, J. M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G. I. Shulman, S. Bonner-Weir, and M. F. White. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904[Medline].

Molecular and Cellular Biology, November 1999, p. 7771-7781, Vol. 19, No. 11
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Leney, S. E, Tavare, J. M (2009). The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol 203: 1-18 [Abstract] [Full Text]  
  • Scazzocchio, B., Vari, R., D'Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., Masella, R. (2009). Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. J. Lipid Res. 50: 832-845 [Abstract] [Full Text]  
  • Zhou, Y., Jiang, L., Rui, L. (2009). Identification of MUP1 as a Regulator for Glucose and Lipid Metabolism in Mice. J. Biol. Chem. 284: 11152-11159 [Abstract] [Full Text]  
  • Ding, J., Du, K. (2009). ClipR-59 Interacts with Akt and Regulates Akt Cellular Compartmentalization. Mol. Cell. Biol. 29: 1459-1471 [Abstract] [Full Text]  
  • Deepa, S. S., Dong, L. Q. (2009). APPL1: role in adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab. 296: E22-E36 [Abstract] [Full Text]  
  • Jo, H., Jia, Y., Subramanian, K. K., Hattori, H., Luo, H. R. (2008). Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation. Mol. Cell. Biol. 28: 4285-4299 [Abstract] [Full Text]  
  • Holland, W. L., Summers, S. A. (2008). Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism. Endocr. Rev. 29: 381-402 [Abstract] [Full Text]  
  • Umahara, M., Okada, S., Yamada, E., Saito, T., Ohshima, K., Hashimoto, K., Yamada, M., Shimizu, H., Pessin, J. E., Mori, M. (2008). Tyrosine Phosphorylation of Munc18c Regulates Platelet-Derived Growth Factor-Stimulated Glucose Transporter 4 Translocation in 3T3L1 Adipocytes. Endocrinology 149: 40-49 [Abstract] [Full Text]  
  • Sevillano, J., de Castro, J., Bocos, C., Herrera, E., Ramos, M. P. (2007). Role of Insulin Receptor Substrate-1 Serine 307 Phosphorylation and Adiponectin in Adipose Tissue Insulin Resistance in Late Pregnancy. Endocrinology 148: 5933-5942 [Abstract] [Full Text]  
  • Saito, T., Jones, C. C., Huang, S., Czech, M. P., Pilch, P. F. (2007). The Interaction of Akt with APPL1 Is Required for Insulin-stimulated Glut4 Translocation. J. Biol. Chem. 282: 32280-32287 [Abstract] [Full Text]  
  • Atsumi, T., Cho, Y.-R., Leng, L., McDonald, C., Yu, T., Danton, C., Hong, E.-G., Mitchell, R. A., Metz, C., Niwa, H., Takeuchi, J., Onodera, S., Umino, T., Yoshioka, N., Koike, T., Kim, J. K., Bucala, R. (2007). The Proinflammatory Cytokine Macrophage Migration Inhibitory Factor Regulates Glucose Metabolism during Systemic Inflammation. J. Immunol. 179: 5399-5406 [Abstract] [Full Text]  
  • Koneru, S., Penumathsa, S. V., Thirunavukkarasu, M., Samuel, S. M., Zhan, L., Han, Z., Maulik, G., Das, D. K., Maulik, N. (2007). Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am. J. Physiol. Heart Circ. Physiol. 292: H2060-H2072 [Abstract] [Full Text]  
  • Wadley, G. D., Konstantopoulos, N., Macaulay, L., Howlett, K. F., Garnham, A., Hargreaves, M., Cameron-Smith, D. (2007). Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training. J. Appl. Physiol. 102: 1624-1631 [Abstract] [Full Text]  
  • Cleasby, M. E., Reinten, T. A., Cooney, G. J., James, D. E., Kraegen, E. W. (2007). Functional Studies of Akt Isoform Specificity in Skeletal Muscle in Vivo; Maintained Insulin Sensitivity Despite Reduced Insulin Receptor Substrate-1 Expression. Mol. Endocrinol. 21: 215-228 [Abstract] [Full Text]  
  • Konstantopoulos, N., Marcuccio, S., Kyi, S., Stoichevska, V., Castelli, L. A., Ward, C. W., Macaulay, S. L. (2007). A Purine Analog Kinase Inhibitor, Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor 59, Reveals a Role for Calcium/Calmodulin-Dependent Protein Kinase II in Insulin-Stimulated Glucose Transport. Endocrinology 148: 374-385 [Abstract] [Full Text]  
  • Hamada, T., Arias, E. B., Cartee, G. D. (2006). Increased submaximal insulin-stimulated glucose uptake in mouse skeletal muscle after treadmill exercise. J. Appl. Physiol. 101: 1368-1376 [Abstract] [Full Text]  
  • Sandu, C., Artunc, F., Palmada, M., Rexhepaj, R., Grahammer, F., Hussain, A., Yun, C., Alessi, D. R., Lang, F. (2006). Impaired intestinal NHE3 activity in the PDK1 hypomorphic mouse. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G868-G876 [Abstract] [Full Text]  
  • Peck, G. R., Ye, S., Pham, V., Fernando, R. N., Macaulay, S. L., Chai, S. Y., Albiston, A. L. (2006). Interaction of the Akt Substrate, AS160, with the Glucose Transporter 4 Vesicle Marker Protein, Insulin-Regulated Aminopeptidase. Mol. Endocrinol. 20: 2576-2583 [Abstract] [Full Text]  
  • Gonzalez, E., McGraw, T. E. (2006). Insulin Signaling Diverges into Akt-dependent and -independent Signals to Regulate the Recruitment/Docking and the Fusion of GLUT4 Vesicles to the Plasma Membrane. Mol. Biol. Cell 17: 4484-4493 [Abstract] [Full Text]  
  • Lowenberg, M., Tuynman, J., Scheffer, M., Verhaar, A., Vermeulen, L., van Deventer, S., Hommes, D., Peppelenbosch, M. (2006). Kinome Analysis Reveals Nongenomic Glucocorticoid Receptor-Dependent Inhibition of Insulin Signaling. Endocrinology 147: 3555-3562 [Abstract] [Full Text]  
  • Sajan, M. P., Rivas, J., Li, P., Standaert, M. L., Farese, R. V. (2006). Repletion of Atypical Protein Kinase C following RNA Interference-mediated Depletion Restores Insulin-stimulated Glucose Transport. J. Biol. Chem. 281: 17466-17473 [Abstract] [Full Text]  
  • Grahammer, F., Henke, G., Sandu, C., Rexhepaj, R., Hussain, A., Friedrich, B., Risler, T., Metzger, M., Just, L., Skutella, T., Wulff, P., Kuhl, D., Lang, F. (2006). Intestinal function of gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1114-G1123 [Abstract] [Full Text]  
  • Matsui, T., Nagoshi, T., Hong, E.-G., Luptak, I., Hartil, K., Li, L., Gorovits, N., Charron, M. J., Kim, J. K., Tian, R., Rosenzweig, A. (2006). Effects of chronic Akt activation on glucose uptake in the heart. Am. J. Physiol. Endocrinol. Metab. 290: E789-E797 [Abstract] [Full Text]  
  • Liu, L.-Z., Zhao, H.-L., Zuo, J., Ho, S. K.S., Chan, J. C.N., Meng, Y., Fang, F.-D., Tong, P. C.Y. (2006). Protein Kinase C{zeta} Mediates Insulin-induced Glucose Transport through Actin Remodeling in L6 Muscle Cells. Mol. Biol. Cell 17: 2322-2330 [Abstract] [Full Text]  
  • Riley, J. K., Carayannopoulos, M. O., Wyman, A. H., Chi, M., Moley, K. H. (2006). Phosphatidylinositol 3-Kinase Activity Is Critical for Glucose Metabolism and Embryo Survival in Murine Blastocysts. J. Biol. Chem. 281: 6010-6019 [Abstract] [Full Text]  
  • Evans, G. J. O., Barclay, J. W., Prescott, G. R., Jo, S.-R., Burgoyne, R. D., Birnbaum, M. J., Morgan, A. (2006). Protein Kinase B/Akt Is a Novel Cysteine String Protein Kinase That Regulates Exocytosis Release Kinetics and Quantal Size. J. Biol. Chem. 281: 1564-1572 [Abstract] [Full Text]  
  • Huang, J., Imamura, T., Babendure, J. L., Lu, J.-C., Olefsky, J. M. (2005). Disruption of Microtubules Ablates the Specificity of Insulin Signaling to GLUT4 Translocation in 3T3-L1 Adipocytes. J. Biol. Chem. 280: 42300-42306 [Abstract] [Full Text]  
  • Hresko, R. C., Mueckler, M. (2005). mTOR{middle dot}RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes. J. Biol. Chem. 280: 40406-40416 [Abstract] [Full Text]  
  • Ruehl, M., Erben, U., Schuppan, D., Wagner, C., Zeller, A., Freise, C., Al-Hasani, H., Loesekann, M., Notter, M., Wittig, B. M., Zeitz, M., Dieterich, W., Somasundaram, R. (2005). The Elongated First Fibronectin Type III Domain of Collagen XIV Is an Inducer of Quiescence and Differentiation in Fibroblasts and Preadipocytes. J. Biol. Chem. 280: 38537-38543 [Abstract] [Full Text]  
  • Thong, F. S. L., Dugani, C. B., Klip, A. (2005). Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway. Physiology 20: 271-284 [Abstract] [Full Text]  
  • Schiffer, M., Susztak, K., Ranalletta, M., Raff, A. C., Bottinger, E. P., Charron, M. J. (2005). Localization of the GLUT8 glucose transporter in murine kidney and regulation in vivo in nondiabetic and diabetic conditions. Am. J. Physiol. Renal Physiol. 289: F186-F193 [Abstract] [Full Text]  
  • Jiang, Z. Y., Zhou, Q. L., Holik, J., Patel, S., Leszyk, J., Coleman, K., Chouinard, M., Czech, M. P. (2005). Identification of WNK1 as a Substrate of Akt/Protein Kinase B and a Negative Regulator of Insulin-stimulated Mitogenesis in 3T3-L1 Cells. J. Biol. Chem. 280: 21622-21628 [Abstract] [Full Text]  
  • Herr, H. J., Bernard, J. R., Reeder, D. W., Rivas, D. A., Limon, J. J., Yaspelkis, B. B. III (2005). Insulin-stimulated plasma membrane association and activation of Akt2, aPKC {zeta} and aPKC {lambda} in high fat fed rodent skeletal muscle. J. Physiol. 565: 627-636 [Abstract] [Full Text]  
  • McCurdy, C. E., Cartee, G. D. (2005). Akt2 Is Essential for the Full Effect of Calorie Restriction on Insulin-Stimulated Glucose Uptake in Skeletal Muscle. Diabetes 54: 1349-1356 [Abstract] [Full Text]  
  • McCurdy, C. E., Davidson, R. T., Cartee, G. D. (2005). Calorie restriction increases the ratio of phosphatidylinositol 3-kinase catalytic to regulatory subunits in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288: E996-E1001 [Abstract] [Full Text]  
  • van Dam, E. M., Govers, R., James, D. E. (2005). Akt Activation Is Required at a Late Stage of Insulin-Induced GLUT4 Translocation to the Plasma Membrane. Mol. Endocrinol. 19: 1067-1077 [Abstract] [Full Text]  
  • Tremblay, F., Gagnon, A., Veilleux, A., Sorisky, A., Marette, A. (2005). Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes. Endocrinology 146: 1328-1337 [Abstract] [Full Text]  
  • Hutchinson, D. S., Bengtsson, T. (2005). {alpha}1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol-3 Kinase-, and Atypical Protein Kinase C-Dependent Pathway. Endocrinology 146: 901-912 [Abstract] [Full Text]  
  • Anderson, M. S., Thamotharan, M., Kao, D., Devaskar, S. U., Qiao, L., Friedman, J. E., Hay, W. W. Jr (2005). Effects of acute hyperinsulinemia on insulin signal transduction and glucose transporters in ovine fetal skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R473-R481 [Abstract] [Full Text]  
  • Gavi, S., Yin, D., Shumay, E., Wang, H.-y., Malbon, C. C. (2005). The 15-Amino Acid Motif of the C Terminus of the {beta}2-Adrenergic Receptor Is Sufficient to Confer Insulin-Stimulated Counterregulation to the {beta}1-Adrenergic Receptor. Endocrinology 146: 450-457 [Abstract] [Full Text]  
  • Kondapaka, S. B., Zarnowski, M., Yver, D. R., Sausville, E. A., Cushman, S. W. (2004). 7-Hydroxystaurosporine (UCN-01) Inhibition of Akt Thr308 but not Ser473 Phosphorylation: A Basis for Decreased Insulin-Stimulated Glucose Transport. Clin. Cancer Res. 10: 7192-7198 [Abstract] [Full Text]  
  • Zeigerer, A., McBrayer, M. K., McGraw, T. E. (2004). Insulin Stimulation of GLUT4 Exocytosis, but Not Its Inhibition of Endocytosis, Is Dependent on RabGAP AS160. Mol. Biol. Cell 15: 4406-4415 [Abstract] [Full Text]  
  • Kim, M. S., Yoon, C. Y., Jang, P. G., Park, Y. J., Shin, C. S., Park, H. S., Ryu, J. W., Pak, Y. K., Park, J. Y., Lee, K. U., Kim, S. Y., Lee, H. K., Kim, Y. B., Park, K. S. (2004). The Mitogenic and Antiapoptotic Actions of Ghrelin in 3T3-L1 Adipocytes. Mol. Endocrinol. 18: 2291-2301 [Abstract] [Full Text]  
  • Campbell, M., Allen, W. E., Sawyer, C., Vanhaesebroeck, B., Trimble, E. R. (2004). Glucose-Potentiated Chemotaxis in Human Vascular Smooth Muscle Is Dependent on Cross-Talk Between the PI3K and MAPK Signaling Pathways. Circ. Res. 95: 380-388 [Abstract] [Full Text]  
  • Gross, D. N., Farmer, S. R., Pilch, P. F. (2004). Glut4 Storage Vesicles without Glut4: Transcriptional Regulation of Insulin-Dependent Vesicular Traffic. Mol. Cell. Biol. 24: 7151-7162 [Abstract] [Full Text]  
  • Sajan, M. P., Standaert, M. L., Miura, A., Bandyopadhyay, G., Vollenweider, P., Franklin, D. M., Lea-Currie, R., Farese, R. V. (2004). Impaired Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 in Cultured Preadipocyte-Derived Adipocytes and Myotubes of Obese Subjects. J. Clin. Endocrinol. Metab. 89: 3994-3998 [Abstract] [Full Text]  
  • Sweeney, G., Garg, R. R., Ceddia, R. B., Li, D., Ishiki, M., Somwar, R., Foster, L. J., Neilsen, P. O., Prestwich, G. D., Rudich, A., Klip, A. (2004). Intracellular Delivery of Phosphatidylinositol (3,4,5)-Trisphosphate Causes Incorporation of Glucose Transporter 4 into the Plasma Membrane of Muscle and Fat Cells without Increasing Glucose Uptake. J. Biol. Chem. 279: 32233-32242 [Abstract] [Full Text]  
  • Standaert, M. L., Sajan, M. P., Miura, A., Kanoh, Y., Chen, H. C., Farese, R. V. Jr., Farese, R. V. (2004). Insulin-induced Activation of Atypical Protein Kinase C, but Not Protein Kinase B, Is Maintained in Diabetic (ob/ob and Goto-Kakazaki) Liver: CONTRASTING INSULIN SIGNALING PATTERNS IN LIVER VERSUS MUSCLE DEFINE PHENOTYPES OF TYPE 2 DIABETIC AND HIGH FAT-INDUCED INSULIN-RESISTANT STATES. J. Biol. Chem. 279: 24929-24934 [Abstract] [Full Text]  
  • Lundgren, M., Buren, J., Ruge, T., Myrnas, T., Eriksson, J. W. (2004). Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes. J. Clin. Endocrinol. Metab. 89: 2989-2997 [Abstract] [Full Text]  
  • Sasaoka, T., Wada, T., Fukui, K., Murakami, S., Ishihara, H., Suzuki, R., Tobe, K., Kadowaki, T., Kobayashi, M. (2004). SH2-containing Inositol Phosphatase 2 Predominantly Regulates Akt2, and Not Akt1, Phosphorylation at the Plasma Membrane in Response to Insulin in 3T3-L1 Adipocytes. J. Biol. Chem. 279: 14835-14843 [Abstract] [Full Text]  
  • Watson, R. T., Kanzaki, M., Pessin, J. E. (2004). Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes. Endocr. Rev. 25: 177-204 [Abstract] [Full Text]  
  • Canto, C., Suarez, E., Lizcano, J. M., Grino, E., Shepherd, P. R., Fryer, L. G. D., Carling, D., Bertran, J., Palacin, M., Zorzano, A., Guma, A. (2004). Neuregulin Signaling on Glucose Transport in Muscle Cells. J. Biol. Chem. 279: 12260-12268 [Abstract] [Full Text]  
  • Vasko, V, Saji, M, Hardy, E, Kruhlak, M, Larin, A, Savchenko, V, Miyakawa, M, Isozaki, O, Murakami, H, Tsushima, T, Burman, K D, De Micco, C, Ringel, M D (2004). Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J. Med. Genet. 41: 161-170 [Abstract] [Full Text]  
  • Hoehn, K. L., Hudachek, S. F., Summers, S. A., Florant, G. L. (2004). Seasonal, tissue-specific regulation of Akt/protein kinase B and glycogen synthase in hibernators. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286: R498-R504 [Abstract] [Full Text]  
  • Perrini, S., Natalicchio, A., Laviola, L., Belsanti, G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., De Pergola, G., Giorgino, R., Giorgino, F. (2004). Dehydroepiandrosterone Stimulates Glucose Uptake in Human and Murine Adipocytes by Inducing GLUT1 and GLUT4 Translocation to the Plasma Membrane. Diabetes 53: 41-52 [Abstract] [Full Text]  
  • Bae, S. S., Cho, H., Mu, J., Birnbaum, M. J. (2003). Isoform-specific Regulation of Insulin-dependent Glucose Uptake by Akt/Protein Kinase B. J. Biol. Chem. 278: 49530-49536 [Abstract] [Full Text]  
  • Ruan, H., Zarnowski, M. J., Cushman, S. W., Lodish, H. F. (2003). Standard Isolation of Primary Adipose Cells from Mouse Epididymal Fat Pads Induces Inflammatory Mediators and Down-regulates Adipocyte Genes. J. Biol. Chem. 278: 47585-47593 [Abstract] [Full Text]  
  • Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., Thompson, C. B. (2003). Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival. Mol. Cell. Biol. 23: 7315-7328 [Abstract] [Full Text]  
  • McCurdy, C. E., Davidson, R. T., Cartee, G. D. (2003). Brief calorie restriction increases Akt2 phosphorylation in insulin-stimulated rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 285: E693-E700 [Abstract] [Full Text]  
  • Chen, X., Al-Hasani, H., Olausson, T., Wenthzel, A.-M., Smith, U., Cushman, S. W. (2003). Activity, phosphorylation state and subcellular distribution of GLUT4-targeted Akt2 in rat adipose cells. J. Cell Sci. 116: 3511-3518 [Abstract] [Full Text]  
  • Beeson, M., Sajan, M. P., Dizon, M., Grebenev, D., Gomez-Daspet, J., Miura, A., Kanoh, Y., Powe, J., Bandyopadhyay, G., Standaert, M. L., Farese, R. V. (2003). Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose Tolerance: Amelioration by Rosiglitazone and Exercise. Diabetes 52: 1926-1934 [Abstract] [Full Text]  
  • Katome, T., Obata, T., Matsushima, R., Masuyama, N., Cantley, L. C., Gotoh, Y., Kishi, K., Shiota, H., Ebina, Y. (2003). Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions. J. Biol. Chem. 278: 28312-28323 [Abstract] [Full Text]  
  • Patel, N., Rudich, A., Khayat, Z. A., Garg, R., Klip, A. (2003). Intracellular Segregation of Phosphatidylinositol-3,4,5-Trisphosphate by Insulin-Dependent Actin Remodeling in L6 Skeletal Muscle Cells. Mol. Cell. Biol. 23: 4611-4626 [Abstract] [Full Text]  
  • Jiang, Z. Y., Zhou, Q. L., Coleman, K. A., Chouinard, M., Boese, Q., Czech, M. P. (2003). Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100: 7569-7574 [Abstract] [Full Text]  
  • Murata, H., Hresko, R. C., Mueckler, M. (2003). Reconstitution of Phosphoinositide 3-Kinase-dependent Insulin Signaling in a Cell-free System. J. Biol. Chem. 278: 21607-21614 [Abstract] [Full Text]  
  • Brozinick, J. T. Jr, Roberts, B. R., Dohm, G. L. (2003). Defective Signaling Through Akt-2 and -3 But Not Akt-1 in Insulin-Resistant Human Skeletal Muscle: Potential Role in Insulin Resistance. Diabetes 52: 935-941 [Abstract] [Full Text]  
  • Asante-Appiah, E., Kennedy, B. P. (2003). Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 284: E663-E670 [Abstract] [Full Text]  
  • Galic, S., Klingler-Hoffmann, M., Fodero-Tavoletti, M. T., Puryer, M. A., Meng, T.-C., Tonks, N. K., Tiganis, T. (2003). Regulation of Insulin Receptor Signaling by the Protein Tyrosine Phosphatase TCPTP. Mol. Cell. Biol. 23: 2096-2108 [Abstract] [Full Text]  
  • Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., Summers, S. A. (2003). A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids. J. Biol. Chem. 278: 10297-10303 [Abstract] [Full Text]  
  • Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., Slamon, D. J. (2003). Overexpression of AKT2/Protein Kinase B{beta} Leads to Up-Regulation of {beta}1 Integrins, Increased Invasion, and Metastasis of Human Breast and Ovarian Cancer Cells. Cancer Res. 63: 196-206 [Abstract] [Full Text]  
  • Ikonomov, O. C., Sbrissa, D., Mlak, K., Shisheva, A. (2002). Requirement for PIKfyve Enzymatic Activity in Acute and Long-Term Insulin Cellular Effects. Endocrinology 143: 4742-4754 [Abstract] [Full Text]  
  • Standaert, M. L., Ortmeyer, H. K., Sajan, M. P., Kanoh, Y., Bandyopadhyay, G., Hansen, B. C., Farese, R. V. (2002). Skeletal Muscle Insulin Resistance in Obesity-Associated Type 2 Diabetes in Monkeys Is Linked to a Defect in Insulin Activation of Protein Kinase C-{zeta}/{lambda}/{iota}. Diabetes 51: 2936-2943 [Abstract] [Full Text]  
  • Gogg, S., Smith, U. (2002). Epidermal Growth Factor and Transforming Growth Factor alpha Mimic the Effects of Insulin in Human Fat Cells and Augment Downstream Signaling in Insulin Resistance. J. Biol. Chem. 277: 36045-36051 [Abstract] [Full Text]  
  • Lhuillier, L., Dryer, S. E. (2002). Developmental Regulation of Neuronal KCa Channels by TGFbeta 1: An Essential Role for PI3 Kinase Signaling and Membrane Insertion. J. Neurophysiol. 88: 954-964 [Abstract] [Full Text]  
  • Ducluzeau, P.-H., Fletcher, L. M., Welsh, G. I., Tavare, J. M. (2002). Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles. J. Cell Sci. 115: 2857-2866 [Abstract] [Full Text]  
  • Farese, R. V. (2002). Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am. J. Physiol. Endocrinol. Metab. 283: E1-E11 [Abstract] [Full Text]  
  • Chen, H. C., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Standaert, M., Farese, R. V. Jr., Farese, R. V. (2002). Activation of the ERK Pathway and Atypical Protein Kinase C Isoforms in Exercise- and Aminoimidazole-4-carboxamide- 1-beta -D-riboside (AICAR)-stimulated Glucose Transport. J. Biol. Chem. 277: 23554-23562 [Abstract] [Full Text]  
  • Kane, S., Sano, H., Liu, S. C. H., Asara, J. M., Lane, W. S., Garner, C. C., Lienhard, G. E. (2002). A Method to Identify Serine Kinase Substrates. Akt PHOSPHORYLATES A NOVEL ADIPOCYTE PROTEIN WITH A Rab GTPASE-ACTIVATING PROTEIN (GAP) DOMAIN. J. Biol. Chem. 277: 22115-22118 [Abstract] [Full Text]  
  • Standaert, M. L., Kanoh, Y., Sajan, M. P., Bandyopadhyay, G., Farese, R. V. (2002). Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-{lambda}, and Glucose Transport in 3T3/L1 Adipocytes. Endocrinology 143: 1705-1716 [Abstract] [Full Text]  
  • Letiges, M., Plomann, M., Standaert, M. L., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Farese, R. V. (2002). Knockout of PKC{alpha} Enhances Insulin Signaling Through PI3K. Mol. Endocrinol. 16: 847-858 [Abstract] [Full Text]  
  • Gronning, L. M., Cederberg, A., Miura, N., Enerback, S., Tasken, K. (2002). Insulin and TNF{alpha} Induce Expression of the Forkhead Transcription Factor Gene Foxc2 in 3T3-L1 Adipocytes via PI3K and ERK 1/2-Dependent Pathways. Mol. Endocrinol. 16: 873-883 [Abstract] [Full Text]  
  • Yu, Y., Alwine, J. C. (2002). Human Cytomegalovirus Major Immediate-Early Proteins and Simian Virus 40 Large T Antigen Can Inhibit Apoptosis through Activation of the Phosphatidylinositide 3'-OH Kinase Pathway and the Cellular Kinase Akt. J. Virol. 76: 3731-3738 [Abstract] [Full Text]  
  • Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Standaert, M. L., Quon, M. J., Lea-Currie, R., Sen, A., Farese, R. V. (2002). PKC-{zeta} Mediates Insulin Effects on Glucose Transport in Cultured Preadipocyte-Derived Human Adipocytes. J. Clin. Endocrinol. Metab. 87: 716-723 [Abstract] [Full Text]  
  • Barnes, K., Ingram, J. C., Porras, O. H., Barros, L. F., Hudson, E. R., Fryer, L. G. D., Foufelle, F., Carling, D., Hardie, D. G., Baldwin, S. A. (2002). Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115: 2433-2442 [Abstract] [Full Text]  
  • Kruszynska, Y. T., Worrall, D. S., Ofrecio, J., Frias, J. P., Macaraeg, G., Olefsky, J. M. (2002). Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation. J. Clin. Endocrinol. Metab. 87: 226-234 [Abstract] [Full Text]  
  • Tardif, A., Julien, N., Pelletier, A., Thibault, G., Srivastava, A. K., Chiasson, J.-L., Coderre, L. (2001). Chronic exposure to beta -hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 281: E1205-E1212 [Abstract] [Full Text]  
  • Somwar, R., Niu, W., Kim, D. Y., Sweeney, G., Randhawa, V. K., Huang, C., Ramlal, T., Klip, A. (2001). Differential Effects of Phosphatidylinositol 3-Kinase Inhibition on Intracellular Signals Regulating GLUT4 Translocation and Glucose Transport. J. Biol. Chem. 276: 46079-46087 [Abstract] [Full Text]  
  • Foster, L. J., Li, D., Randhawa, V. K., Klip, A. (2001). Insulin Accelerates Inter-endosomal GLUT4 Traffic via Phosphatidylinositol 3-Kinase and Protein Kinase B. J. Biol. Chem. 276: 44212-44221 [Abstract] [Full Text]  
  • Lang, F., Cohen, P. (2001). Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms. Sci Signal 2001: re17-re17 [Abstract] [Full Text]  
  • Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., Birnbaum, M. J. (2001). Akt1/PKBalpha Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice. J. Biol. Chem. 276: 38349-38352 [Abstract] [Full Text]  
  • James, D. J., Cairns, F., Salt, I. P., Murphy, G. J., Dominiczak, A. F., Connell, J. M.C., Gould, G. W. (2001). Skeletal Muscle of Stroke-Prone Spontaneously Hypertensive Rats Exhibits Reduced Insulin-Stimulated Glucose Transport and Elevated Levels of Caveolin and Flotillin. Diabetes 50: 2148-2156 [Abstract] [Full Text]  
  • Ono, H., Katagiri, H., Funaki, M., Anai, M., Inukai, K., Fukushima, Y., Sakoda, H., Ogihara, T., Onishi, Y., Fujishiro, M., Kikuchi, M., Oka, Y., Asano, T. (2001). Regulation of Phosphoinositide Metabolism, Akt Phosphorylation, and Glucose Transport by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) in 3T3-L1 Adipocytes. Mol. Endocrinol. 15: 1411-1422 [Abstract] [Full Text]  
  • Takano, A., Haruta, T., Iwata, M., Usui, I., Uno, T., Kawahara, J., Ueno, E., Sasaoka, T., Kobayashi, M. (2001). Growth Hormone Induces Cellular Insulin Resistance by Uncoupling Phosphatidylinositol 3-Kinase and Its Downstream Signals in 3T3-L1 Adipocytes. Diabetes 50: 1891-1900 [Abstract] [Full Text]  
  • Konrad, D., Somwar, R., Sweeney, G., Yaworsky, K., Hayashi, M., Ramlal, T., Klip, A. (2001). The Antihyperglycemic Drug {alpha}-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation: Potential Role of p38 Mitogen-Activated Protein Kinase in GLUT4 Activation. Diabetes 50: 1464-1471 [Abstract] [Full Text]  
  • Kanoh, Y., Bandyopadhyay, G., Sajan, M. P., Standaert, M. L., Farese, R. V. (2001). Rosiglitazone, Insulin Treatment, and Fasting Correct Defective Activation of Protein Kinase C-{{zeta}}/{{lambda}} by Insulin in Vastus Lateralis Muscles and Adipocytes of Diabetic Rats. Endocrinology 142: 1595-1605 [Abstract] [Full Text]  
  • Farese, R. V. (2001). Insulin-Sensitive Phospholipid Signaling Systems and Glucose Transport. Update II. Exp. Biol. Med. 226: 283-295 [Abstract] [Full Text]  
  • Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A., Maehama, T., Dixon, J. E., Donner, D. B. (2001). A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 10.1073/pnas.051042298v1 [Abstract] [Full Text]  
  • Kido, Y., Nakae, J., Accili, D. (2001). The Insulin Receptor and Its Cellular Targets. J. Clin. Endocrinol. Metab. 86: 972-979 [Abstract] [Full Text]  
  • Bandyopadhyay, G., Kanoh, Y., Sajan, M. P., Standaert, M. L., Farese, R. V. (2000). Effects of Adenoviral Gene Transfer of Wild-Type, Constitutively Active, and Kinase-Defective Protein Kinase C-{lambda} on Insulin-Stimulated Glucose Transport in L6 Myotubes. Endocrinology 141: 4120-4127 [Abstract] [Full Text]  
  • Foster, L. J., Klip, A. (2000). Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. Am. J. Physiol. Cell Physiol. 279: C877-C890 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, M. M.
Right arrow Articles by Macaulay, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, M. M.
Right arrow Articles by Macaulay, S. L.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»